Research Reports Coverage on Biotech Stocks -- OncoGenex Pharma, INSYS Therapeutics, Threshold Pharma, and ...
Yahoo Finance Moreover, shares of OncoGenex Pharma, which develops and commercializes therapies that address treatment resistance in cancer patients, have a Relative Strength Index (RSI) of 51.35. On January 05th, 2017, ... The Company stated that AB-SA01 met the ... and more » |
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2j8bHr1
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου